Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Implementing Goals of Care Notes in a Statewide Health System: A Quality Improvement Initiative.
Journal: The American journal of medicine
Published: November 19, 2024
Providing Palliative Care to Patients Throughout the State of Indiana from a Centralized Virtual Palliative Care Hub.
Journal: Joint Commission journal on quality and patient safety
Published: April 14, 2022
Polo-like kinase 1 as a therapeutic target for malignant peripheral nerve sheath tumors (MPNST) and schwannomas.
Journal: American journal of cancer research
Published: December 18, 2019
Aurora A kinase inhibition enhances oncolytic herpes virotherapy through cytotoxic synergy and innate cellular immune modulation.
Journal: Oncotarget
Published: November 07, 2016
CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin.
Journal: Oncotarget
Published: March 10, 2016
An ShRNA Screen Identifies MEIS1 as a Driver of Malignant Peripheral Nerve Sheath Tumors.
Journal: EBioMedicine
Published: February 08, 2016
Fatty acid synthase is a metabolic oncogene targetable in malignant peripheral nerve sheath tumors.
Journal: Neuro-oncology
Published: December 19, 2014
Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 20, 2012
Neurotrophin-4 regulates the survival of gustatory neurons earlier in development using a different mechanism than brain-derived neurotrophic factor.
Journal: Developmental biology
Published: October 03, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026